Stocktoria
Axogen, Inc. AXGN
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1986-12-17
Axogen, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $225.2M | $187.3M | $159.0M | $138.6M | $127.4M |
| Gross profit | $167.4M | $142.0M | $121.9M | $108.8M | $104.4M |
| R&D expense | $32.9M | $27.8M | $27.3M | $25.6M | $24.2M |
| Operating income | -$7.8M | -$3.3M | -$21.5M | -$29.7M | -$25.4M |
| Interest expense | — | — | $2.8M | $624,000 | $1.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$15.7M | -$10.0M | -$21.7M | -$28.9M | -$27.0M |
| EPS (diluted) | $-0.34 | $-0.23 | $-0.51 | $-0.69 | $-0.65 |
| Operating cash flow | $812,000 | $4.5M | -$5.7M | -$16.1M | -$13.4M |
| Free cash flow | -$2.9M | $1.4M | -$19.6M | -$36.1M | -$41.2M |
| Cash & equivalents | $35.5M | $27.6M | $31.0M | $15.3M | $32.8M |
| Inventory | $42.4M | $33.2M | $23.0M | $18.9M | $16.7M |
| Total assets | $221.7M | $203.7M | $196.8M | $195.4M | $208.0M |
| Total liabilities | $92.8M | $99.8M | $101.2M | $94.4M | $95.5M |
| Shareholders' equity | $128.8M | $103.9M | $95.7M | $101.0M | $112.5M |
Source: SEC EDGAR filings · CIK 0000805928 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.